Thursday, 16 December 2010

Electronic patient-reported outcome solutions

ERT, a provider of technology and services to the pharmaceutical, biotechnology and medical device industries,today announced the launch of its comprehensive suite of electronic patient-reported outcome (ePRO) solutions. As the ePRO market continues to grow, ePRO tools have increasingly become more sophisticated, with their development reflecting the diverse needs of sponsors and facilitating compliance by the patient. ERT now offers a broad range of proven modalities of technology, offering the ability to choose the best ePRO solution to suit the requirements of the trial, ensuring its accuracy and success.

The selection of the ideal ePRO modality is reliant on multiple factors including questionnaire complexity, length, site location, patient
population, budget and size of trial. To facilitate this complex selection criteria, ERT offers a diverse range of complementary ePRO tools accepted by regulatory authorities globally for collection of reliable accurate data.

ERT solutions include the VIAPhone, VIAPad, VIAPen and VIAWeb, all of which offer the advantages of simplicity, mobility and immediacy of use over traditional paper based methods.

ERT's VIAPad solution has the capacity for complex diaries, questionnaires and visual scales, alongside the ability to streamline mid-study changes.

The VIAWeb solution enables all patients to use a standard internet browser at home or work to securely log into their study diary or assessment and complete necessary information. This is ideal for patients busy at work, with little time to visit a clinical trial site. The VIAPen is a digital pen that offers the simplicity of paper-based methods with the dual advantage of digital data collection. Completing the suite of solutions offered is the VIAPhone, otherwise known as an Interactive Voice Response device. The VIAPhone enables a patient to use a standard landline telephone or cell phone to feedback information. For people reluctant to embrace more innovative technologies or with reduced physical function, this provides the perfect solution.

John Blakeley, Executive Vice President and Chief Commercial Officer at ERT comments: "At ERT we believe that 'one size does NOT fit all.' We believe that to ensure an accurate and successful clinical trial, vendors must offer technologies that are as diverse and varied as the clinical trials themselves. With this in mind, ERT works to ensure that it offers a comprehensive, unbiased choice of sophisticated solutions."